Ann: Wattle Health Australia Commences Trading on the ASX, page-67

I have to review the figures after checking them , once again sales in FY22 get up t0 $13.6m with 50% year on year growth for 5 years post FY2017 assumed revenue of $1.8m , cost of sales same as before 60% of FY22 assumed $13.6m revenue or around $8m , i forgot to subtract this $8m figure from the revenue before to give gross profit , if i do it now it comes to $5.6m gross profit , now comparing expenses at Bal over past few years it looks like they come to around 25% of revenue so in this assumption FY22 expenses of $3.4m (excluding new product development costs) giving an after tax profit of $1.54m or a PE of 18.6 at today's 25c share price.

So in effect the current share price is forward looking till 2022 .

Are people expecting WHA to grow sales faster than 50% year on year ?? , its Baby formula is nothing special like Bals Organic product or the A2M product.